Prot # X05317: A Phase 2 Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD

Project: Research project

Project Details

StatusFinished
Effective start/end date10/23/0910/23/18

Funding

  • Millennium Pharmaceuticals, Inc. (X05317)